iBio (IBIO) Asset Utilization Ratio (2011 - 2026)

iBio's (IBIO) quarterly Asset Utilization Ratio came in at 0.0 in Q1 2026, down 78.27% year-on-year from 0.02 in Q1 2025, and down 14.43% on a QoQ basis from 0.0 in Q4 2025.

iBio (IBIO) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

iBio (IBIO) has 16 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 78.27% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 78.27% decrease from a year earlier, with the FY2025 full-year figure at 0.02, up 139.49% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.0, down from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IBIO reached as high as 0.03 in Q4 2022 and fell as low as 0.0 in Q1 2024.
  • Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2025.
  • Across the five-year window, Asset Utilization Ratio slumped 94.72% in 2023 and surged 1447.35% in 2025, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2022, then slumped by 94.72% to 0.0 in 2023, then soared by 1063.61% to 0.02 in 2024, then sank by 71.24% to 0.0 in 2025, then retreated by 14.43% to 0.0 in 2026.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.01 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.69
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.37
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 iBio 172.22 Mn 172.22 Mn - 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.01
Jun 30, 2025 0.02
Mar 31, 2025 0.02
Dec 31, 2024 0.02
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Dec 31, 2022 0.03
Sep 30, 2022 0.02
Jun 30, 2022 0.02
Mar 31, 2022 0.02
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.02
Mar 31, 2021 0.02
Dec 31, 2020 0.02